Currently, surgery is the only option for clinical management of jaw deformity resulting from midfacial hypoplasia and foramen magnum stenosis (Bagley et al. 2006) . We previously showed that C-type natriuretic peptide (CNP), a member of the natriuretic peptide family , is a potent stimulator of endochondral ossification (Chusho et al. 2001 ) and is dependent on guanylyl cyclase-B (GC-B)-mediated intracellular cGMP production . Further, CNP and GC-B are both expressed in the growth plates of long bones and vertebrae, and mice lacking CNP or GC-B exhibit severely impaired growth of these bones (Chusho et al. 2001; Tamura et al. 2004) . We recently demonstrated that the CNP/GC-B system in the growth plate stimulates the proliferation of chondrocytes in the proliferative chondrocyte layer (Nakao et al. 2015) . By contrast, mice with elevated circulatory CNP or targeted overexpression of CNP in growth plate cartilage exhibit prominent skeletal overgrowth (Yasoda et al. 2004; Kake et al. 2009; Yasoda et al. 2009 ) and longitudinal overgrowth along the cranial length through endochondral ossification (Nakao et al. 2013; Nakao et al. 2016) .
Based on these findings, we hypothesized that the CNP/ GC-B system represents a novel therapeutic target for the treatment of craniofacial hypoplasia in achondroplasia. To test this idea, we studied the effect of CNP on craniofacial hypoplasia in achondroplasia, using a mouse model of achondroplasia in which FGFR3 is specifically activated in cartilage.
Materials and Methods

Animals
Mice were housed in the specific pathogen-free animal facility of the Graduate School of Medicine, Kyoto University, under a 12-h light/dark cycle with ad libitum access to standard rodent diet and tap water. Animal care and experiments were conducted in accordance with institutional guidelines.
Mice expressing activated FGFR3 in the cartilage (Fgfr3 ach mice) were generated on a FVB/N background using the Col2a1 promoter and enhancer sequences, as previously described (Naski et al. 1998) . Mice expressing mouse CNP in the liver under the control of the human serum amyloid-P (SAP)component promoter (SAP-Nppc-Tg mice) were generated on a C57BL/B6 background as previously described. These mice have elevated circulating CNP levels, and plasma CNP concentrations measured by radioimmunoassay (RIA) were 84% higher in SAP-Nppc-Tg mice than in wild-type (WT) mice (Kake et al. 2009 ). Fgfr3 ach and SAP-Nppc-Tg mice were crossed to generate Fgfr3 ach mice with elevated circulatory CNP levels (Fgfr3 ach / SAP-Nppc-Tg mice). In this study, all achondroplastic mice were heterozygous for the Fgfr3 ach transgene. We used female F1 mixed-background (C57BL/B6; FVB/N) mice (WT, Fgfr3 ach , and Fgfr3 ach /SAP-Nppc-Tg) in all experiments. The genetic background of the controls in the present study is different from the previous one (Naski et al. 1998 ). The study conformed to ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines for preclinical studies.
Skull Imaging
Three-dimensional reconstructions were generated by microcomputed tomography (µCT, SMX-100CT-SV3; Shimadzu Co.). µCT data were analyzed according to linear measurements and Euclidean distance matrix analysis (EDMA, http:// www.getahead.psu.edu/) as described previously (Richtsmeier et al. 2000; Arron et al. 2006; Nakao et al. 2013 ). In addition, soft x-ray analyses were performed using an SRO-M5 system (30 kVp, 5 mA for 1 min; Softron). The size of the foramen magnum was measured using the ImageJ software (National Institutes of Health).
Organ and Micromass Cultures
Cranial bases and nasal septal cartilage (NSC) were obtained from neonatal WT or Fgfr3 ach mice. Organ cultures of cranial bases and occipital bones treated with vehicle or 10 −7 M CNP for 6 d were used to measure the length of the spheno-occipital synchondrosis (SOS), intersphenoidal synchondrosis (ISS), and anterior intraoccipital synchondrosis (AIOS) using a dissecting microscope equipped with linear ocular scale (10×; MZFL-III; Leica Microsystems) (Lei et al. 2008; Nakao et al. 2013) . Micromass chondrocytes from NSC were cultured with vehicle or 10 −7 M CNP for 3 wk and subsequently fixed with 10% formalin, embedded in paraffin, cut into 5-µm sections, and stained with Alcian blue/hematoxylin and eosin (HE) (Nakao et al. 2013 ).
Histology
Five-micron sections were cut from paraffin-embedded horizontal sections of cranial base and subsequently deparaffinized, rehydrated, stained with Alcian blue, and counterstained with HE (Muto Pure Chemicals Co.) as previously described (Nakao et al. 2013 ).
Immunohistochemistry
Type I and type II collagen (1310-10 and 1320-01; SBA), type X collagen (LB-0092; LSL), and von Willebrand factor (A0082; DAKO) were detected in tissue sections using the appropriate monoclonal antibodies.
TUNEL and BrdU Analysis
Target skeletal tissues were harvested 2 h after intraperitoneal injection of 5-bromo-2′-deoxyuridine (BrdU; 10 mL/kg; Nacalai), fixed overnight in 4% paraformaldehyde, and subsequently decalcified in 0.5 M EDTA for 2 wk. Samples were then embedded in paraffin and sectioned to detect BrdUpositive cells using anti-BrdU antibody (11296736001; Roche). Proliferation index was defined as the number of BrdU-positive nuclei, expressed as a percentage of the total number of nuclei in the proliferation zone in the SOS.
Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) was performed under light microscopy (S7100; Millipore).
Real-Time Reverse-Transcription Polymerase Chain Reaction
Total RNA was extracted using the RNeasy Mini Kit (Qiagen) from NSC-derived micromass chondrocytes treated with vehicle or 10 −7 M CNP for 10 d. Reverse-transcription polymerase chain reaction (RT-PCR) was performed as previously described (Nakao et al. 2013 ). Real-time RT-PCR was performed in a StepOne real-time PCR System (Applied Biosystems).
Statistical Analysis
Data are expressed as means ± standard error of the mean (SEM). Statistical analysis was performed in Excel (Microsoft) by analysis of variance (ANOVA) using Fisher's least significant difference method, and P values <0.05 were considered statistically significant. A nonparametric statistical technique was used for EDMA.
Supplemental Information
Detailed materials and methods (manufacturer, experimental condition, tables of the number of mice, etc.) are in the online Appendix.
Results
Morphologic Analyses of Skulls of WT, Fgfr3 ach , and Fgfr3 ach /SAP-Nppc-Tg Mice Fgfr3 ach mice exhibited dwarfism and short limb bones ( Fig.  1A, B ). Skulls of Fgfr3 ach mice were longitudinally shorter than those of WT mice, as observed in skeletal preparations (Fig. 1C ). µCT images were used for morphometric analyses of skulls from Fgfr3 ach mice ( Fig. 1D ). Nasal bone, upper jaw, and skull lengths in Fgfr3 ach mice were significantly shorter than those of WT mice (Fig. 1E ). However, skull widths and inner-canthal distances were significantly larger in Fgfr3 ach than in WT crania ( Fig. 1E ). EDMA confirmed that nasal, premaxilla, maxilla, and frontal bones were markedly affected sagittally, resulting in hypoplasia in Fgfr3 ach crania (Fig. 1F ). Conversely, cranial width was larger in Fgfr3 ach than in WT crania ( Fig. 1F ). µCT imaging revealed that both occipital and sphenoid bones that make the skull base were shorter in Fgfr3 ach than in WT mice ( Fig. 1G, H) . To study the effects of circulatory CNP on midfacial hypoplasia in Fgfr3 ach mice, we generated Fgfr3 ach mice with increased circulatory CNP levels by cross-mating Fgfr3 ach and SAP-Nppc-Tg mice. The resultant progeny (Fgfr3 ach /SAP-Nppc-Tg mice) exhibited attenuation of the Fgfr3 ach skeletal phenotype (Fig. 1A, B ), consistent with our earlier report (Yasoda et al. 2009 ). Furthermore, hypoplasia of the skulls observed in Fgfr3 ach mice was markedly attenuated in Fgfr3 ach /SAP-Nppc-Tg mice (Fig. 1C, D) . Linear measurements obtained from µCT images revealed significantly improved skull length and nasal bone length in Fgfr3 ach / SAP-Nppc-Tg mice (Fig. 1E ). EDMA revealed that the hypoplasia observed in Fgfr3 ach skulls was partially attenuated in Fgfr3 ach /SAP-Nppc-Tg skulls (Fig. 1F ). Furthermore, the sphenoid bones were significantly improved and the occipital bones were partially improved in Fgfr3 ach /SAP-Nppc-Tg mice (Fig.  1G, H) .
Histological Analyses of SOS in WT, Fgfr3 ach , and Fgfr3 ach /SAP-Nppc-Tg Mice Because endochondral ossification of the SOS determines the length of the skull base, the SOS is an important growth center in craniomaxillofacial skeletogenesis. We investigated the role of FGFR3 and determined the effect of CNP in synchondrosis closure using Alizarin red and Alcian blue staining of skull base preparations and Alcian blue/HE-stained horizontal sections in 10-d-old WT, Fgfr3 ach , and Fgfr3 ach /SAP-Nppc-Tg mice. In comparison with WT mice, skull bases of Fgfr3 ach mice exhibited 16.5% thinner SOS with ossification at the center of the SOS ( Fig. 2A, B ). Although the thickness of the SOS was significantly larger in Fgfr3 ach /SAP-Nppc-Tg than in Fgfr3 ach mice (Fig. 2C) , SOS ossification was observed in Fgfr3 ach /SAP-Nppc-Tg but not in WT mice (Fig. 2B ). Premature synchondrosis ossification was observed in 64% of Fgfr3 ach and 71% of Fgfr3 ach /SAP-Nppc-Tg mice at 1 wk old.
Immunostaining for type I collagen (marker of ossification) confirmed that synchondrosis ossification occurred at the center of SOS ( Fig. 2D ) in Fgfr3 ach skull base. In addition, staining of type II (marker for nonhypertrophic chondrocyte layer; Fig.  2E ) and type X collagens (marker of hypertrophic chondrocyte differentiation; Fig. 2F ) revealed that both nonhypertrophic and hypertrophic chondrocyte layers were reduced.
Synchondrosis ossification also occurred at the center of the SOS in the Fgfr3 ach /SAP-Nppc-Tg skull base ( Fig. 2D) , whereas both the nonhypertrophic and hypertrophic chondrocyte layers were thicker in Fgfr3 ach /SAP-Nppc-Tg than in Fgfr3 ach mice and comparable to those in WT mice ( Fig.  2E, F) .
Cells positive for von Willebrand factor, a marker of vascular endothelia, and for TUNEL, a marker of apoptosis, were clearly identifiable at the center ( Fig. 2G ) and edges ( Fig. 2H) , respectively, of the type I collagen-positive area of the SOS in Fgfr3 ach and Fgfr3 ach /SAP-Nppc-Tg mice.
We also examined the proliferation of chondrocytes in this region by staining for incorporated BrdU. BrdU-positive cells were clearly detected in the center of the type I collagen-positive area of the SOS in Fgfr3 ach and Fgfr3 ach /SAP-Nppc-Tg mice and in the proliferative zone in WT, Fgfr3 ach , and Fgfr3 ach / SAP-Nppc-Tg mice. The proportions of BrdU-positive chondrocytes were significantly lower in the proliferating layer of synchondroses in Fgfr3 ach than in WT mice (Fig. 2I) . The proportions of BrdU-positive chondrocytes were clearly higher in Fgfr3 ach /SAP-Nppc-Tg than in Fgfr3 ach mice (Fig. 2I, J) . 
Histological Analyses of ISS in WT, Fgfr3 ach , and Fgfr3 ach /SAP-Nppc-Tg Mice
The ISS, a synchondrosis of the skull base, also contributes to the cranial base length, specifically of the sphenoid bone. The Alcian blue/HE-stained horizontal sections of the ISS revealed that the ISS was significantly 22.1% thinner in Fgfr3 ach than in WT mice. The narrowing of the ISS observed in Fgfr3 ach mice was also rescued in Fgfr3 ach /SAP-Nppc-Tg mice, as in the SOS. Furthermore, we observed premature ossification from the edge of the ISS in some Fgfr3 ach and Fgfr3 ach /SAP-Nppc-Tg mice but not in WT mice (Fig. 2K, L) .
Organ Culture Experiments of Skull Base from WT and Fgfr3 ach Mice
To elucidate the effects of activated FGFR3 on the growth of ISS and SOS, as well as the effects of CNP on the growth of the ISS and SOS in Fgfr3 ach mice, we performed organ culture experiments using skull base explants from neonatal Fgfr3 ach and WT mice (Fig. 3A) . At the end of a 6-d culture period, the ISS and SOS of skull base explants from Fgfr3 ach mice were approximately 9.6% and 3.3% shorter than those of WT explants, respectively (Fig. 3B, C) . Treatment of Fgfr3 ach skull base with CNP significantly increased the lengths of the ISS and SOS (Fig. 3A-C) .
Micromass Culture of NSC from WT and Fgfr3 ach Mice
Because the growth of the NSC is essential for longitudinal facial growth (Wealthall and Herring 2006) , we examined the growth of chondrocytes from NSC of WT and Fgfr3 ach mice in micromass culture. Histological evaluation revealed that the micromass was significantly 9.7% thinner in Fgfr3 ach than in WT. CNP significantly increased the thickness of micromass chondrocytes from Fgfr3 ach NSC (Fig. 3D, E) . Furthermore, CNP treatment resulted in enlarged chondrocytes and increased the extracellular space, as observed in Alcian blue-stained sections (Fig. 3D) . Expression levels of chondrogenic differentiation markers in the micromass, particularly aggrecan, one of the major structural components of cartilage, and type X collagen were higher following CNP treatment (Fig. 3F) . 
Morphologic Analyses of Foramen Magnum of WT, Fgfr3 ach , and Fgfr3 ach /SAP-Nppc-Tg Mice
To determine whether CNP is effective for treatment of foramen magnum stenosis caused by activation of FGFR3, we compared this region in WT, Fgfr3 ach , and Fgfr3 ach /SAP-Nppc-Tg skulls (Fig. 4A) . At 12 wk, the size of the foramen magnum was significantly smaller (-11.3%) in Fgfr3 ach than in WT skulls. The narrowed foramen magnum of Fgfr3 ach was rescued in Fgfr3 ach /SAP-Nppc-Tg mice (Fig. 4B ).
Histological Analysis of Foramen Magnum in WT, Fgfr3 ach , and Fgfr3 ach /SAP-Nppc-Tg Mice
The foramen magnum is bound by the exoccipital, supraoccipital, and basooccipital bones, which develop and grow by endochondral ossification (Di Rocco et al. 2014) . The AIOS stands between the exoccipital and basoccipital bones, and the posterior intraoccipital synchondrosis (PIOS) stands between the exoccipital and supraoccipital bone (Fig. 4C) . Staining of the AIOS with Alcian blue/HE revealed thinner synchondrosis in Fgfr3 ach than in WT mice at 10 d old (Fig. 4D, E) . Hypoplasia of the AIOS in Fgfr3 ach mice was rescued by cross-mating with SAP-Nppc-Tg mice (Fig. 4E ). On the other hand, although not observed in WT mice, synchondrosis ossification occurred at the PIOS in Fgfr3 ach and Fgfr3 ach /SAP-Nppc-Tg mice at 10 d old (Fig. 4C, D) .
Organ Culture Experiments of Foramen Magnum from WT and Fgfr3 ach Mice
To elucidate the effects of activated FGFR3 on the growth of the AIOS and the effects of CNP on AIOS growth in Fgfr3 ach mice, we performed organ culture experiments using occipital bones from neonatal Fgfr3 ach and WT mice ( Fig. 4F) . At the end of a 6-d culture period, the AIOSs of occipital bones from Fgfr3 ach mice were approximately 27.5% shorter than those in WT explants (Fig. 4G ). Treatment with CNP during the culture period attenuated the hypoplasia of the AIOS in explants from Fgfr3 ach mice (Fig. 4F, G ).
Discussion
In this study, we analyzed the craniofacial morphology of Fgfr3 ach mice and the mechanisms of jaw deformities caused by an achondroplasia-related mutation in FGFR3. Fgfr3 ach mice exhibited maxillary hypoplasia similar to that of humans carrying the analogous mutation, as well as premature closure of the synchondrosis, consistent with previous reports ). Furthermore, we found that premature synchondrosis closure initiates at the center of SOS in Fgfr3 ach mice.
The premature synchondrosis closure was led by premature loss of proliferating chondrocytes, increased angiogenesis to the center of the SOS, and increased bone formation. Increased angiogenesis and bone formation further accelerated closure of the synchondrosis and fusion at ossification centers, and chondrocytes at the chondro-osseous junction of the SOS also underwent increased apoptosis. Histological assessment indicated reduced thickness of the hypertrophic and nonhypertrophic chondrocyte layers at the SOS and ISS in Fgfr3 ach mice. Furthermore, in vitro organ and micromass culture studies suggested that FGFR3 signaling inhibited endochondral bone growth in the skull base and nasal septum. Consequently, Fgfr3 ach mice crania exhibited hypoplasia in the sagittal direction, probably due to premature closure of the synchondrosis and impaired endochondral ossification. On the other hand, the elevated cranial width in Fgfr3 ach mice could be attributed to increase intracranial pressure prior to fusion of the skull. This symptom is similar to the macrocephaly depending on hydrocephalus, observed in children with achondroplasia (Erdinçler et al. 1997) .
In this experiment, foramen magnum stenosis, another typical feature also observed in achondroplasia patients, occurred in Fgfr3 ach mice, and histological analysis revealed ossification of the PIOS and thinner AIOS in 10-d-old Fgfr3 ach mice. Based on these results, we concluded that the foramen magnum stenosis in Fgfr3 ach mice was caused by premature closure and impaired endochondral bone growth of the synchondroses of the foramen magnum, as in the synchondroses of the skull base.
Our earlier studies indicated that both systemic administration and targeted overexpression of CNP in cartilage attenuate impaired skeletal growth in the limbs and vertebrae of Fgfr3 ach mice (Yasoda et al. 2004) . Treatments with a CNP analogue also significantly restored bone growth in another mouse model of achondroplasia (Lorget et al. 2012 ). In addition to treating short stature, we hypothesized that the strong stimulatory effect of CNP on endochondral ossification could be useful in treating midfacial hypoplasia and foramen magnum stenosis in achondroplasia. To test this idea, we generated Fgfr3 ach /SAP-Nppc-Tg mice with elevated plasma CNP concentrations (Kake et al. 2009 ). The choice to use a liver targeted rather than a cartilage targeted CNP overexpressing mice is because it mimics intravascular administration of CNP. Consistent with this, Fgfr3 ach /SAP-Nppc-Tg mice exhibited attenuated midfacial hypoplasia, possibly due to restoration of the thickness of the synchondrosis and promotion of the proliferation of chondrocytes in the craniofacial cartilage. The hypertrophic chondrocyte layers showed the most noticeable improvement. By promoting endochondral bone growth of the AIOS, Fgfr3 ach /SAP-Nppc-Tg mice exhibited attenuated foramen magnum stenosis. Furthermore, in organ culture experiments using the skull base and occipital bone, as well as micromass cultures with NSCs, CNP increased matrix production and promoted the growth of hypertrophic chondrocytes in craniofacial cartilage of Fgfr3 ach mice. Together, these results suggest that CNP may be useful in treating achondroplasiarelated skull deformities.
We previously showed that CNP reverses the effects of FGFR3 signaling, which suppresses the proliferation and differentiation of growth plate chondrocytes and ultimately endochondral bone growth by inhibiting the MAPK pathway in tibiae (Yasoda et al. 2004) . Because FGFR3 signaling promotes closure of the synchondrosis and fusion of ossification centers through the MAPK pathway ), we hypothesized that the stimulatory effect of CNP also inhibits these processes. However, CNP did not suppress premature ossification of the SOS or PIOS in Fgfr3 ach /SAP-Nppc-Tg mice. This lack of effect could be explained in 2 ways. First, early expression of CNP may be critical, and CNP expression in SAP-Nppc-Tg mice (which only occurs postnatally in this model) may have been too late (Zhao et al. 1992) . Second, the circulating CNP concentration may have been too low to suppress ossification. These results indicate that early administration of CNP or a CNP analogue may be an important determinant of clinical effectiveness.
In summary, maxillary hypoplasia and foramen magnum stenosis caused by premature closure of the synchondrosis and impaired endochondral ossification in Fgfr3 ach mice could be partially rescued by overexpression of CNP, thereby promoting endochondral ossification of craniofacial cartilage. CNP might be an effective therapy for the impaired skeletogenesis in the craniofacial region, including midfacial hypoplasia and narrowing of the foramen magnum, observed in patients with achondroplasia. Because administration of CNP or a CNP analogue is required before premature closure of the synchondrosis, early administration may be an important determinant of clinical effectiveness.
